NeuBase Therapeutics, Inc. (NBSE)

NASDAQ: NBSE · IEX Real-Time Price · USD

0.420

+0.007 (1.69%)

At close: Apr 22, 2024, 4:00 PM

0.400

-0.020 (-4.76%)

After-hours: Apr 22, 2024, 6:19 PM EDT

NeuBase Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2004
Net Income	-33.78	-25.41	-17.38	-26.13	-13.24	-23.81	-25.77	-15.2	-9.13	-5.65	Upgrade
Depreciation & Amortization	1.26	0.58	0.28	0.13	1.12	1.17	1.19	1.18	0.47	0.09	Upgrade
Share-Based Compensation	2.9	3.7	5.19	8.96	1.02	2.11	4.67	4.22	2.07	1.02	Upgrade
Other Operating Activities	0.6	2.26	1.2	14.2	1.6	1.24	3.92	-0.89	1.23	1.86	Upgrade
Operating Cash Flow	-29.01	-18.87	-10.71	-2.85	-9.49	-19.29	-15.99	-10.69	-5.36	-2.69	Upgrade
Capital Expenditures	-0.47	-1.44	-0.72	-0.46	0.53	0.09	-0.01	-0.18	-0	0	Upgrade
Acquisitions	0	-1.1	0	-0.18	0	0	0	-0.1	-3.51	0	Upgrade
Change in Investments	-0	-0.03	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-0.05	-	-	-	-	-	-	Upgrade
Investing Cash Flow	-0.47	-2.56	-0.72	-0.69	0.53	0.09	-0.01	-0.28	-3.51	0	Upgrade
Share Issuance / Repurchase	0	42.73	33.46	13.23	0.27	19.7	0.03	26.66	17.14	5.25	Upgrade
Debt Issued / Paid	-0.26	-0.39	-0.35	0.51	-0.36	-0.24	-0.18	-0.21	-0.16	-0.07	Upgrade
Other Financing Activities	-	-	-	-0.14	-	-	-	-	-	-	Upgrade
Financing Cash Flow	-0.26	42.34	33.11	13.6	-0.09	19.46	-0.15	26.45	16.97	5.18	Upgrade
Net Cash Flow	-29.74	20.9	21.68	10.06	-9.05	0.25	-16.15	15.48	8.1	2.49	Upgrade
Free Cash Flow	-29.48	-20.31	-11.43	-3.3	-8.96	-19.2	-16	-10.88	-5.36	-2.69	Upgrade
Free Cash Flow Per Share	-18.15	-14.88	-11.65	-7.98	-63.58	-171.56	-204.16	-153.19	-96.85	-57.51	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).